GSIA Educational Course 2010 „Operational Excellence in the Pharmaceutical Industry“
Registration
Summary
Operational Excellence (OPEX) is a philosophy of leadership, teamwork and problem solving resulting in continuous improvement throughout an organization by focusing on the needs of the customer, empowering employees, and optimizing existing activities in the process. Its ultimate goal for the organization is to become a better enterprise. Many pharmaceutical companies believe they truly implemented OPEX. However, most are far away from meeting this goal. Shortcomings typically occur in
- Total Productive Maintenance (TPM)
- Total Quality Management (TQM)
- Just in Time (JIT) development and supply chain management
- the application of these principles not only in production but also in development.
In the view of the GSIA it is an imperative for a conscientious associate working in one of the various disciplines of the Pharmaceutical Industry to understand the drivers for OPEX, how OPEX is implemented, how it can change our working environment and how it will shape and change the job profiles of the future. Moreover, GSIA believes that high motivation and competence of all associates is a prerequisite to foster the leading position of Switzerland in the pharmaceutical industry. Therefore, GSIA invites you all to join this year's educational course dedicated to OPEX. The organization is in cooperation with the Schuh Complexity Management Group AG , ms medical communication services and the University of St. Gallen . The course is split up into four afternoons. Each afternoon is comprehensively covering the respective topic. Thus, you are welcomed to select individual session, if you can't participate in all courses.
Interview with the Organizers
"Goal, Topics, Lecturers and benefits of attending the course" (in German). By Dr. Jürgen Werani, Prof. Dr. Thomas Friedli and Priv.-Doz Dr. Dr. Lorenz Meinel.
Read the full interview with the organizers (in German) 416.71 Kb
| Dieses Interview im Vorfeld der GSIA Fortbildungstagung vom Herbst 2010 ist erschienen in SWISS PHARMA (Schweizerische Zeitschrift für die pharmazeutische Industrie), Nr. 6, Juni 2010. Abonnemente und Einzelhefte liefert der Verlag. |
SWISS PHARMA Verlag Dr. Felix Wüst AG In der Hinterzelg 4 CH-8700 Küsnacht ZH Fax +41 (0)44 918 29 70 E-Mail This e-mail address is being protected from spam bots, you need JavaScript enabled to view it |
What Participants can expect
- Understanding the strategic drivers of technical drug development, supply chain management and production in the pharmaceutical industry and critical discussion on Operational Excellence (OpEx) initiatives over the past ten years
- How these imperatives have changed and will change our working environment and how we can personally prepare ourselves to remain competitive in the future
- Innovative concepts in asset management, contract manufacturing, outsourcing models, continuous supply management, the control of process variability and design space and continuous manufacturing as well as other topics
- Cutting edge lectures reporting experience from top pharmaceutical companies and academic institutions followed by a real-life case study and discussion
- Exclusive access to supplemental information through our password coded GSIA Homepage (provided upon registration)
Key Facts:
- Dates: October 29, November 5, and 12, in each date from 14h to 17h. Note: November 19 event is from 12:30h - 15:30h!
- Location: Basel, Novartis Campus (October 29, November 5, and 12 in the Gehry Building and for November 19 in the Auditorium 510)
- Attendance fees: CHF 400.- for non-GSIA members; CHF 300.- for GSIA members, students and trainees and CHF 150.- for an individual session
In Cooperation with:
 |
 |
 |
Congress Programme
Friday October 29th (14h to 17h), Gehry Building
| Topic | Name | Time | |
|---|---|---|---|
| 1 | Framework and OpEx model - TPM | ||
| 1a | Welcome | Tom van Laar Global Head TechOps Novartis |
15 min |
| 1b | Operational excellence in the pharmaceutical industry (The HSG Model) |
Prof. Dr. Thomas Friedli Institute of Technology Management University of St. Gallen |
45 min |
| 1c | Case study: Study Results | Matthias Götzfried Institute of Technology Management University of St. Gallen |
20 min |
| Break | 30 min | ||
| 1d | Asset management in the pharmaceutical industry | Dipl.-Ing. Cord Winter FIR (Forschungsinstitut für Rationalisierung) RWTH Aachen |
45 min |
| 1e | Case Study: Asset care improvment program at Novartis | Thomas Wilhelm Head Knowledge Management Global Pharma Engineering Novartis |
20 min |
Online subscription to this afternoon
Friday November 5th (14h to 17h), Gehry Building
|
|
Topic | Name | Time | |
| 2 | Innovation - TQM - JIT |
|
|
|
| 2a | Clinical Trial Excellence - An integrated Management Model | Niels Volkmer Institute of Technology Management University of St. Gallen |
60 min | |
| Break | 30 min | |||
| 2b | Innovative concepts in supply chain management (From Product Development to Market) |
Dr. Christian Ewers |
45 min | |
| 2c | Performance improvement through automated workflows | Dr. Juergen Betzing COO Mepha Aesch BL |
30 min | |
| 2d | Process optimization and QbD |
Georg Bernhard |
30 min | |
Online subscription to this afternoon
Friday November 12th (14h to 17h), Gehry Building
|
|
Topic | Name | Time |
| 3 | Leadership - Innovation |
|
|
| 3a | Process Variability and Design Space (the regulatory environment for OPEX) |
Prabir K. Basu, PhD |
60 min |
| 3b | Case study: Overcoming the inertia | Thomas Gronauer Institute of Technology Management University of St. Gallen |
30 min |
| Break | 30 min | ||
| 3c | Employee engagement in difficult times: securing a sustainable future in a globalized environment | Dr. Regina Hauser Head Human Resources Pfizer Manufacturing Germany |
60 min |
Online subscription to this afternoon
Friday November 19th (12:30h - 15:30h), Auditorium 510
|
|
Topic | Name | Time |
| 4 | Innovation - Conclusion |
|
|
| 4a | Continuous manufacturing: the Ultra Lean way of manufacturing | Dr. Walter Bisson Novartis AG |
45 min |
| 4b | Case study: Discussion about the consequences of continuous manufacturing | Dr. Walter Bisson Novartis AG |
30 min |
| Break | 30 min | ||
| 4c | The Lean challenges and weaknesses |
Dr. Giuseppe Bellando- Randone |
60 min |
| 4d | Closing remarks | GSIA / Prof. Dr. Thomas Friedli | 15 min |
Online subscription to this afternoon
